Emily Farrington

459 total citations
7 papers, 303 citations indexed

About

Emily Farrington is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Physiology. According to data from OpenAlex, Emily Farrington has authored 7 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 3 papers in Epidemiology and 3 papers in Physiology. Recurrent topics in Emily Farrington's work include Asthma and respiratory diseases (3 papers), Inhalation and Respiratory Drug Delivery (2 papers) and Herpesvirus Infections and Treatments (1 paper). Emily Farrington is often cited by papers focused on Asthma and respiratory diseases (3 papers), Inhalation and Respiratory Drug Delivery (2 papers) and Herpesvirus Infections and Treatments (1 paper). Emily Farrington collaborates with scholars based in United Kingdom, United States and Italy. Emily Farrington's co-authors include Louise Heron, Federico Lavorini, Richard Dekhuijzen, Jonathan Marshall, Omar S. Usmani, Stephanie James, Richard Perry, Lisa Elliott, Mark Lebwohl and Ketty Peris and has published in prestigious journals such as SHILAP Revista de lepidopterología, Value in Health and Respiratory Research.

In The Last Decade

Emily Farrington

6 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emily Farrington United Kingdom	4	245	216	25	18	17	7	303
Ferran Chuecos Spain	9	295 1.2×	240 1.1×	18 0.7×	8 0.4×	6 0.4×	20	324
Allyson Larkin United States	5	83 0.3×	139 0.6×	31 1.2×	32 1.8×	16 0.9×	9	222
Ji‐Su Shim South Korea	7	65 0.3×	113 0.5×	15 0.6×	7 0.4×	8 0.5×	22	178
Gianni Passalacqua Italy	11	57 0.2×	158 0.7×	196 7.8×	83 4.6×	5 0.3×	12	300
Iida Vähätalo Finland	8	122 0.5×	147 0.7×	27 1.1×		4 0.2×	22	184
Laura Padullés Spain	7	258 1.1×	172 0.8×		10 0.6×	15 0.9×	17	311
Richard Forth United Kingdom	11	395 1.6×	411 1.9×	18 0.7×		11 0.6×	24	447
Cristina M. Bastardo United Kingdom	7	245 1.0×	191 0.9×	11 0.4×	2 0.1×	36 2.1×	9	290
Dana V. Wallace United States	3	58 0.2×	84 0.4×	32 1.3×	5 0.3×	4 0.2×	3	102
Gemma Vilà-Nadal United Kingdom	6	69 0.3×	82 0.4×	31 1.2×	18 1.0×	5 0.3×	12	121

Countries citing papers authored by Emily Farrington

Since Specialization

Citations

This map shows the geographic impact of Emily Farrington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Farrington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Farrington more than expected).

Fields of papers citing papers by Emily Farrington

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Farrington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Farrington. The network helps show where Emily Farrington may publish in the future.

Co-authorship network of co-authors of Emily Farrington

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Farrington. A scholar is included among the top collaborators of Emily Farrington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Farrington. Emily Farrington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Scully, Marie, Tina Dutt, Will Lester, et al.. (2022). Unmet needs in the management of immune‐mediated thrombotic thrombocytopenic purpura and the potential role of caplacizumab in the UK—A modified‐Delphi study. SHILAP Revista de lepidopterología. 3(3). 619–627. 2 indexed citations

2.

James, Stephanie, et al.. (2019). The impact of perennial allergic rhinitis with/without allergic asthma on sleep, work and activity level. Allergy Asthma and Clinical Immunology. 15(1). 81–81. 24 indexed citations

3.

Usmani, Omar S., Federico Lavorini, Jonathan Marshall, et al.. (2018). Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes. Respiratory Research. 19(1). 10–10. 254 indexed citations

4.

Iadeluca, Laura, et al.. (2017). Maternal Screening And Treatment For Group B Streptococcus (GBS) Are Associated With Non-Adherence To Guidelines, False-Negative Results And High Management Costs In The United Kingdom, Italy, France, Spain And Germany. Value in Health. 20(9). A797–A798. 2 indexed citations

5.

Foley, Peter, Eggert Stockfleth, Ketty Peris, et al.. (2016). Adherence to topical therapies in actinic keratosis: A literature review. Journal of Dermatological Treatment. 27(6). 538–545. 17 indexed citations

6.

Farrington, Emily, et al.. (2016). FP/FORM Versus FP/SAL Within Clinical Practice: An Updated Budget Impact Analysis in Asthma. Advances in Therapy. 33(5). 794–806. 4 indexed citations

7.

Farrington, Emily. (1992). Acyclovir in the treatment of chickenpox.. PubMed. 18(5). 499–503.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact